Wave Life Sciences, Inc.
WVE
Jodie situation report
Wave Life Sciences, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 32 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- WVE's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if WVE's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind WVE
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TAKTakeda Pharmaceutical Company LimitedpartnerFeb 26, 2026 ▾
“Revenue for the year ended December 31, 2024 was $108.3 million, and was earned under the GSK Collaboration Agreement ($37.0 million) and the Takeda Collaboration Agreement ($71.3 million).”
Depended on by
KRYSKrystal Biotech, Inc. Common StockpartnerFeb 17, 2026 ▾
“17 • Gene Editing Approaches: We are aware of companies, such as Wave Life Sciences Ltd.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
WVE is currently a Follower in the organic co-movement group Consumer Discretionary. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.